Results
|
1.
|
|
|
2.
|
|
|
3.
|
Phase I study of sunitinib plus modified FOLFOX6 in Japanese patients with treatment-naive colorectal cancer. [electronic resource] by
- Yoshino, Takayuki
- Yamazaki, Kentaro
- Hamaguchi, Tetsuya
- Shimada, Yasuhiro
- Kato, Ken
- Yasui, Hirofumi
- Boku, Narikazu
- Lechuga, Maria Jose
- Hirohashi, Tomoko
- Shibata, Atsushi
- Hashigaki, Satoshi
- Li, Yinhua
- Ohtsu, Atsushi
Producer: 20120508
In:
Anticancer research vol. 32
Availability: No items available.
|
|
4.
|
First-line sunitinib plus FOLFIRI in Japanese patients with unresectable/metastatic colorectal cancer: a phase II study. [electronic resource] by
- Tsuji, Yasushi
- Satoh, Taroh
- Tsuji, Akihito
- Muro, Kei
- Yoshida, Motoki
- Nishina, Tomohiro
- Nagase, Michitaka
- Komatsu, Yoshito
- Kato, Takeshi
- Miyata, Yoshinori
- Mizutani, Naoko
- Hashigaki, Satoshi
- Lechuga, Maria Jose
- Denda, Tadamichi
Producer: 20130507
In:
Cancer science vol. 103
Availability: No items available.
|
|
5.
|
Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib. [electronic resource] by
- Harmon, Charles S
- DePrimo, Samuel E
- Raymond, Eric
- Cheng, Ann-Lii
- Boucher, Eveline
- Douillard, Jean-Yves
- Lim, Ho Y
- Kim, Jun S
- Lechuga, Maria José
- Lanzalone, Silvana
- Lin, Xun
- Faivre, Sandrine
Producer: 20111122
In:
Journal of translational medicine vol. 9
Availability: No items available.
|
|
6.
|
Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II Study. [electronic resource] by
- Kudo, Masatoshi
- Kang, Yoon-Koo
- Park, Joong-Won
- Qin, Shukui
- Inaba, Yoshitaka
- Assenat, Eric
- Umeyama, Yoshiko
- Lechuga, Maria José
- Valota, Olga
- Fujii, Yosuke
- Martini, Jean-Francois
- Williams, J Andrew
- Obi, Shuntaro
Publication details: Liver cancer May 2018
In:
Liver cancer vol. 7
Availability: No items available.
|
|
7.
|
A Phase Ib Study of Axitinib in Combination with Crizotinib in Patients with Metastatic Renal Cell Cancer or Other Advanced Solid Tumors. [electronic resource] by
- Michaelson, M Dror
- Gupta, Shilpa
- Agarwal, Neeraj
- Szmulewitz, Russell
- Powles, Thomas
- Pili, Roberto
- Bruce, Justine Yang
- Vaishampayan, Ulka
- Larkin, James
- Rosbrook, Brad
- Wang, Erjian
- Murphy, Danielle
- Wang, Panpan
- Lechuga, Maria Josè
- Valota, Olga
- Shepard, Dale R
Producer: 20200727
In:
The oncologist vol. 24
Availability: No items available.
|
|
8.
|
Sunitinib versus sorafenib in advanced hepatocellular cancer: results of a randomized phase III trial. [electronic resource] by
- Cheng, Ann-Lii
- Kang, Yoon-Koo
- Lin, Deng-Yn
- Park, Joong-Won
- Kudo, Masatoshi
- Qin, Shukui
- Chung, Hyun-Cheol
- Song, Xiangqun
- Xu, Jianming
- Poggi, Guido
- Omata, Masao
- Pitman Lowenthal, Susan
- Lanzalone, Silvana
- Yang, Liqiang
- Lechuga, Maria Jose
- Raymond, Eric
Producer: 20140107
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
9.
|
Clinical outcomes of patients with advanced gastrointestinal stromal tumors: safety and efficacy in a worldwide treatment-use trial of sunitinib. [electronic resource] by
- Reichardt, Peter
- Kang, Yoon-Koo
- Rutkowski, Piotr
- Schuette, Jochen
- Rosen, Lee S
- Seddon, Beatrice
- Yalcin, Suayib
- Gelderblom, Hans
- Williams, Charles C
- Fumagalli, Elena
- Biasco, Guido
- Hurwitz, Herbert I
- Kaiser, Pamela E
- Fly, Kolette
- Matczak, Ewa
- Chen, Liang
- Lechuga, Maria José
- Demetri, George D
Producer: 20150626
In:
Cancer vol. 121
Availability: No items available.
|
|
10.
|
Correlation of KIT and PDGFRA mutational status with clinical benefit in patients with gastrointestinal stromal tumor treated with sunitinib in a worldwide treatment-use trial. [electronic resource] by
- Reichardt, Peter
- Demetri, George D
- Gelderblom, Hans
- Rutkowski, Piotr
- Im, Seock-Ah
- Gupta, Sudeep
- Kang, Yoon-Koo
- Schöffski, Patrick
- Schuette, Jochen
- Soulières, Denis
- Blay, Jean-Yves
- Goldstein, David
- Fly, Kolette
- Huang, Xin
- Corsaro, Massimo
- Lechuga, Maria Jose
- Martini, Jean-Francois
- Heinrich, Michael C
Producer: 20160930
In:
BMC cancer vol. 16
Availability: No items available.
|
|
11.
|
Randomized, placebo-controlled, phase III trial of sunitinib plus prednisone versus prednisone alone in progressive, metastatic, castration-resistant prostate cancer. [electronic resource] by
- Michaelson, M Dror
- Oudard, Stephane
- Ou, Yen-Chuan
- Sengeløv, Lisa
- Saad, Fred
- Houede, Nadine
- Ostler, Peter
- Stenzl, Arnulf
- Daugaard, Gedske
- Jones, Robert
- Laestadius, Fredrik
- Ullèn, Anders
- Bahl, Amit
- Castellano, Daniel
- Gschwend, Juergen
- Maurina, Tristan
- Chow Maneval, Edna
- Wang, Shaw-Ling
- Lechuga, Maria Jose
- Paolini, Jolanda
- Chen, Isan
Producer: 20140303
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 32
Availability: No items available.
|